Abnormalities in the serum insulin-like growth factor-1 axis in women with hyperandrogenism

Fertility and Sterility

Volumn 70, Issue 6, 1998, Pages 1090-1100

  Escobar Morreale, Héctor F ^a   Serrano Gotarredona, Joaquín ^a   García Robles, Rafael ^a   Varela, César ^a   Sancho, José M ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Adrenal; Functional androgen excess; Growth hormone; Hirsutism; Hyperandrogenism; Insulin like growth factor 1; Insulin like growth factor binding protein 3; Ovary

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CORTICOTROPIN; CORTODOXONE; CYTOCHROME P450 ISOENZYME; ESTRADIOL; FOLLITROPIN; GLUCOSE; GONADORELIN; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; TETRACOSACTIDE; TRIPTORELIN;

ADRENAL GLAND; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HIRSUTISM; HUMAN; HYPERANDROGENISM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; OVARY FUNCTION; PRIORITY JOURNAL; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL;

ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; FEMALE; HIRSUTISM; HUMAN GROWTH HORMONE; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; ISOENZYMES; OVARY; STEROID 17-ALPHA-HYDROXYLASE; TRIPTORELIN;

EID: 0032403591     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00388-4     Document Type: Article

References (28)

1. Knochenhauer E.S., Cortet-Rudelli C., Cunningham R.D., Conway-Myers B.A., Dewailly D., Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab. 82:1997;479-485.
2. Escobar-Morreale H., Pazos F., Potau N., García-Robles R., Sancho J.M., Varela C. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperandrogenism role of adrenal and ovarian cytochrome P450c17 alpha . Fertil Steril. 62:1994;521-530.
3. Escobar-Morreale H.F., Serrano-Gotarredona J., García-Robles R., Sancho J., Varela C. Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenism. Fertil Steril. 67:1997;654-662.
4. Escobar-Morreale H.F., Serrano Gotarredona J., García-Robles R., Sancho J., Varela C. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia does idiopathic hirsutism exist? Metabolism. 46:1997;902-907.
5. Ehrmann D.A., Barnes R.B., Rosenfield R.L. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 16:1995;322-353.
6. Techatraisk K., Conway G.S., Rumsby G. Frequency of a polymorphism in the regulatory region of the 17α-hydroxylase (CYP17) gene in hyperandrogenic states. Clin Endocrinol (Oxf). 46:1997;131-134.
7. Sharara F.I., Nieman L.K. Identification and cellular localization of growth hormone receptor gene expression in the human ovary. J Clin Endocrinol Metab. 79:1994;670-672.
8. Mason H.D., Martikainen H., Beard R.W., Anyaoku V., Franks S. Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro. J Endocrinol. 126:1990;R1-R4.
9. Magoffin D.A., Weitsman S.R. Differentiation of ovarian thecainterstitial cells in vitro regulation of 17α-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulin-like growth factor-I . Endocrinology. 132:1993;1945-1951.
10. Mesiano S., Katz S.L., Lee J.Y., Jaffe R.B. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells implications for adrenal androgen regulation . J Clin Endocrinol Metab. 82:1997;1390-1396.
11. l'Allemand D., Penhoat A., Lebrethon M.C., Ardevol R., Baehr V., Oelkers W., et al. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J Clin Endocrinol Metab. 81:1996;3892-3897.
12. Nestler J.E., Jakubowicz D.J. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 335:1996;617-623.
13. Nobels F., Dewailly D. Puberty and polycystic ovarian syndrome the insulin/insulin-like growth factor I hypothesis . Fertil Steril. 58:1992;655-666.
14. Kazer R.R., Unterman T.G., Glick R.P. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 71:1990;958-962.
15. Hatasaka H.H., Kazer R.R., Chatterton R.T., Unterman T.G., Glick R.P. The response of the growth hormone and insulin-like growth factor I axis to medical castration in women with polycystic ovarian syndrome. Fertil Steril. 62:1994;273-278.
16. Prelevic G.M., Wurzburger M.I., Balint-Peric L., Ginsburg J. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm Res. 37:1992;125-131.
17. Lee E.J., Lee B.S., Lee H.C., Park K.H., Song C.H., Huh K.B. Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome. Fertil Steril. 60:1993;53-57.
18. Urdl W., Desoye G., Schmon B., Hofmann H.M., Ralph G. Interactions between insulin and insulin-like growth factor I in the pathogenesis of polycystic ovarian disease. Ann N Y Acad Sci. 626:1991;177-183.
19. Escobar-Morreale H.F., Serrano-Gotarredona J., Varela C., García-Robles R., Sancho J.M. Circulating leptin concentrations in women with hirsutism. Fertil Steril. 68:1997;898-906.
20. Escobar-Morreale H.F., Serrano-Gotarredona J., Avila S., Villar-Palasí J., Varela C., Sancho J. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J Clin Endocrinol Metab. 83:1998;2580-2584.
21. Ibáñez L., Potau N., Zampolli M., Riqué S., Saenger P., Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab. 82:1997;2283-2288.
22. Ibáñez L., Potau N., Georgopoulos N., Prat N., Gussinyé M., Carrascosa A. Growth hormone, insulin-like growth factor-I axis, and insulin secretion in hyperandrogenic adolescents. Fertil Steril. 64:1995;1113-1119.
23. Ibáñez L., Potau N., Virdis R., Zampolli M., Terzi C., Gussinyé M., et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood increased frequency of functional ovarian hyperandrogenism . J Clin Endocrinol Metab. 76:1993;1599-1603.
24. Morales A.J., Laughlin G.A., Butzow T., Maheshwari H., Baumann G., Yen S.S. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome common and distinct features . J Clin Endocrinol Metab. 81:1996;2854-2864.
25. Azziz R., Deal C.L., Potter H.D., Gargosky S.E., Rosenfeld R.G. Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women. J Clin Endocrinol Metab. 79:1994;1747-1751.
26. Klinger B., Anin S., Silbergeld A., Eshet R., Laron Z. Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol (Oxf). 48:1998;81-87.
27. Clark P.A., Rogol A.D. Growth hormones and sex steroid interactions at puberty. Endocrinol Metab Clin North Am. 25:1996;665-681.
28. Mowszowicz I., Melanitou E., Kirchoffer M.D., Mauvais-Jarvis P. Dihydrotestosterone stimulates 5α-reductase activity in pubic skin fibroblasts. J Clin Endocrinol Metab. 79:1978;29-34.